Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNCET: Low sodium oxybate for nocturnal cluster headache
2025-523293-17-00Phase 2Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in Cluster Headache (CH) comparing Low sodium oxybate with Placebo (2 arms). Primary endpoint: Change in average weekly frequency of nocturnal cluster headache attacks. Planned start Jul 2026; status: authorised.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2025-523293-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523293-17-00.